Guest guest Posted September 15, 2009 Report Share Posted September 15, 2009 There sure is hope for treatment of CMT 1A in 3-5 years. Are you not familiar with STAR? http://www.charcot-marie-tooth.org/STAR.php Project 1 has been completed http://www.charcot-marie-tooth.org/STAR_update2.php http://www.charcot-marie-tooth.org/headlines/117/Latest-Research-Presented-at--C\ MT-Consortium-Abstracts-Now-Available/ Lonaprisan research is ongoing in Germany visit this site to read about it from the Consortium papers http://www.charcot-marie-tooth.org/headlines/117/Latest-Research-Presented-at--C\ MT-Consortium-Abstracts-Now-Available/arch Because CMT 1A affects 70% of people with CMT, that type is being tested first, followed by Types X and 2. With high thoroughput screening and partnerning with pharmaceuticals, we will be seeing much more research soon. Nerve growth factors and gene silencing are but two other projects ongoing worldwide. Gretchen Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.